Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (16)

2024

  1. Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy

    Microorganisms, Vol. 12, Núm. 4

  2. Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain

    Journal of Hospital Infection, Vol. 151, pp. 173-185

2023

  1. Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2291-2296

  2. Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 20

2022

  1. Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia

    Microorganisms, Vol. 10, Núm. 4

  2. Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors

    Pathogens, Vol. 11, Núm. 10

  3. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)

    Microbiology Spectrum, Vol. 10, Núm. 3

2021

  1. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4

  2. Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: Protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)

    Trials, Vol. 21, Núm. 1

  3. Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study

    Clinical Microbiology and Infection, Vol. 26, Núm. 4, pp. 499-505

2019

  1. Erratum to “Spanish Clinical Guidelines on Vascular Access for Haemodialysis” [(NEFROLOGÍA) (2019) 39(1) (1–2), (S0211699518301048), (10.1016/j.nefro.2018.07.001)]

    Nefrologia

  2. Erratum: Fe de errores de Guía Clínica Española del Acceso Vascular para Hemodiálisis (Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia (2017) 37 Suppl 1 (1-191) PII: S0211-6995(19)30153-5)

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia

  3. Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study

    BMJ Open, Vol. 9, Núm. 5

2018

  1. Anti-Basal Ganglia Antibodies and Streptococcal Infection in ADHD

    Journal of Attention Disorders, Vol. 22, Núm. 9, pp. 864-871

2017

  1. Executive summary of management of prosthetic joint infections. Clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 3, pp. 189-195